Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 52090-52092 [2024-13611]
Download as PDF
52090
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Institute of Electrical
and Electronics Engineers, Inc.
Notice is hereby given that, on April
11, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Institute of
Electrical and Electronics Engineers,
Inc. (‘‘IEEE’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 32 new standards have
been initiated, and 3 existing standards
are being revised. More detail regarding
these changes can be found at: https://
standards.ieee.org/about/sasb/sba/
21mar2024/.
The following pre-standards activities
associated with IEEE Industry
Connections Activities were launched
or renewed: https://standards.ieee.org/
about/bog/cag/approvals/april2024/.
On September 17, 2004, the IEEE filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on November 3, 2004 (69
FR 64105).
The last notification was filed with
the Department on February 20, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on April 16, 2024 (89 FR 26922).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13618 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
ddrumheller on DSK120RN23PROD with NOTICES1
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—R Consortium, Inc.
Notice is hereby given that, on April
22, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), R Consortium, Inc.
(‘‘R Consortium’’) has filed written
notifications simultaneously with the
VerDate Sep<11>2014
17:46 Jun 20, 2024
Jkt 262001
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Arcus Biosciences Inc.,
Hayward, CA; and Sanofi, Bridgewater,
NJ, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and R Consortium
intends to file additional written
notifications disclosing all changes in
membership.
On September 15, 2015, R Consortium
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on October 2, 2015 (80
FR 59815).
The last notification was filed with
the Department on January 29, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on March 13, 2024 (89 FR 18438).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13629 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on April
2, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical Technology
Enterprise Consortium (‘‘MTEC’’), has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 10x National Security,
Aldie, VA; 4WEB, Inc., Frisco, TX;
Abram Scientific, Inc., South San
Francisco, CA; Admetsys Corp., Boston,
MA; Advanced RNA Vaccine
Technologies, Inc., North Bethesda, MD;
Aergility Corp., Dunnellon, FL; Airway
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Shield S.L., Santander Cantabria, Spain;
AmacaThera, Inc., Toronto, CANADA;
Ampel LLC, Charlottesville, VA; Anthos
Group, Inc., Torrance, CA; Apos US
Management, Inc., New York, NY;
Asynchealth, Pebble Beach, CA;
Baebies, Inc., Durham, NC; Best Practice
Associates LLC dba Tria Federal,
Arlington, VA; Bio-Change, Ltd.,
Yokneam, ISRAEL; Black Fur
Biomedical, Tucson, AZ; Blue Spark
Technologies, Inc., Westlake, OH; Board
of Regents, Nevada System of Higher
Education on behalf of the University of
Nevada, Las Vegas, Las Vegas, NV;
Board of the Trustees of the Colorado
School of Mines, Golden, CO; Cadet
NM, Inc., Albuquerque, NM; Cambridge
Research & Development, Inc., Nashua,
NH; Canaery, Alachua, FL;
Coldplasmatech GmbH, Greifswald,
GERMANY; ComeBack Mobility, Inc.,
New York, NY; CoolSpine LLC,
Woodbury, CT; Cristae Consulting LLC,
Moorestown, NJ; Directed Systems, Ltd.,
Cambridge, UNITED KINGDOM;
Eluciderm, Inc., San Diego, CA; ExThera
Medical Corp., Martinez, CA; EyeYon
Medical, Ltd., Ness Ziona, ISRAEL;
Florida Institute of Technology,
Melbourne, FL; FluidForm, Inc.,
Waltham, MA; Gigantor Technologies,
Inc., Melbourne Beach, FL; Global
Virtual Training LLC, New York, NY;
GoodCap Pharmaceuticals, Toronto,
CANADA; Hatch Product Development
LLC, Waukegan, IL; Henley Ion LLC,
New Orleans, LA; Idea Meds, Inc., New
York, NY; Immense Dynamics, Inc.,
Bremerton, WA; Innovative Health
Sciences LLC, Chester, NY; Innovosens
AB, Inc., Wilmington, DE;
Interoperability Institute LLC, Lansing,
MI; JustBard Technologies LLC,
Brunswick, MD; KaloCyte, Inc.,
Baltimore, MD; LaCire LLC, Alexandria,
VA; Lankenau Institute for Medical
Research, Wynnewood, PA; Loma Linda
University, Loma Linda, CA; Lucid
Reality Labs LLC, Miami, FL; LumaFlo,
Inc., Detroit, MI; Lundquist Institute for
Medical Innovation at Harbor-UCLA
Medical Center, Torrance, CA;
Medasense Biometrics, Ltd., Ramat Gan,
ISRAEL; MediCarbone, Inc., Tuscon,
AZ; Mitochon Pharmaceuticals, Inc.,
Blue Bell, PA; Modular Matter, Inc.,
Abingdon, MD; Moonrise Medical, Inc.,
Oakville, CANADA; Noleus
Technologies, Inc., Houston, TX; Nou
Systems, Inc., Huntsville, AL; Noxy
Health Products, Inc., Anaconda, MT;
Oak Grove Technologies, Raleigh, NC;
Obsidian Solutions Group,
Fredericksburg, VA; Omniox, Inc., San
Francisco, CA; Osetomics LLC, Glen
Mills, PA; Osteolyse, Inc., Soda Springs,
CA; Owl Therapeutics, San Antonio,
E:\FR\FM\21JNN1.SGM
21JNN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
TX; PathKeeper Surgical, Ltd., Kfar
Saba, ISRAEL; PyrAmes, Inc.,
Cupertino, CA; Qidni Labs, Inc., Buffalo,
NY; Rafa Laboratories, Ltd., Jerusalem,
ISRAEL; ReBlood Rx LLC, San Diego,
CA; Regerna Therapeutics, Inc., New
York, NY; Regulatory Quality
Management Information Source, Inc.,
Amesbury, MA; Remedor Biomed Ltd.,
Nof Hagalil, ISRAEL; Renovera, PBC,
West Lafayette, IN; Respair, Inc.,
Pittsburgh, PA; RevBio, Inc., Lowell,
MA; Rion, Inc., Rochester, MN; Saforax
Health, Haifa, ISRAEL; SCHOTT North
America New Ventures, Duryea, PA;
SenseVOC LLC, Littleton, CO; Serda
B.V., Amsterdam, THE NETHERLANDS;
SMSbiotech, Inc., San Marcos, CA;
Stanford University, Stanford, CA;
STEER Tech LLC, Annapolis Junction,
MD; Synapstim Ltd., Herzliya, ISRAEL;
Temple University—Of The
Commonwealth System of Higher
Education, Philadelphia, PA; The
Hospital for Special Surgery Fund, Inc.,
New York, NY; The Institute for
Integrative and Innovative Research at
the University of Arkansas, Fayetteville,
Fayetteville, AK; Tietronix Software,
Inc., Houston, TX; TYBR Health, Inc.,
Houston, TX; Unit Medical Devices,
Ltd., Sderot, ISRAEL; University of
Arkansas, Little Rock, Little Rock, AR;
University of Cincinnati, Cincinnati,
OH; Valiant Harbor International LLC,
Bethesda, MD; Vasomune Therapeutics
US, Inc., Raleigh, NC; Velico Medical,
Inc., Beverly, MA; ViBo Health, Inc., Los
Angeles, CA; Videra Health, Inc., Orem,
UT; Vir Biotechnology, San Francisco,
CA; ViyaMD, Inc., Marina del Rey, CA;
Western Michigan University Homer
Stryker M.D. School of Medicine,
Kalamazoo, MI; and XO Armor
Technologies, Inc., Auburn, AL have
been added as parties to this venture.
Also, 2C4 Technologies, Inc., San
Antonio, TX; AbViro LLC, Bethesda,
MD; Acer Therapeutics, Inc., Newton,
MA; Advanced Surgical Retractor
Systems, Inc., Shavano Park, TX; Allied
Technologies and Consulting LLC,
Frederick, MD; Amend Surgical, Inc.,
Alachua, FL; American Military
Families Action Network, Tacoma, WA;
American Type Culture Collection,
Manassas, VA; AMK Technologies of
Ohio LLC, Mount Vernon, OH; Anchor
Therapy Clinic, Sacramento, CA;
Applied Research Center, Aiken, SC;
Arcascope, Inc., Arlington, VA; Aruna
Bio, Inc., Athens, GA; Asante Bio,
Tampa, FL; Atorvia Health
Technologies, Inc., Ottawa, Ontario,
CANADA; Avel eCare LLC, Sioux Falls,
SD; Axioforce, Inc., St. Louis, MO; Bio1
Systems, Inc., San Carlos, CA; BioAge
Labs, Inc., Richmond, CA; Biobeat
VerDate Sep<11>2014
17:46 Jun 20, 2024
Jkt 262001
Technologies, Ltd., Petach Tikva,
ISRAEL; Bionet Sonar, Inc., Burlington,
MA; BiotechPharma Corp., Severna
Park, MD; Board of Trustees of the
University of Illinois, Champaign, IL;
Bodies Done Right, Mayfield Village,
OH; California Service Dog Academy,
Visalia, CA; Capital Factory Properties
LLC, Austin, TX; Channel Clinical
Solutions LLC, Raleigh, NC; Children’s
Hospital Los Angeles, Los Angeles, CA;
ClearCoast USA LLC, St. Petersburg, FL;
Concurrent Technologies Corp.,
Johnstown, PA; Conseqta Technology,
Arlington, VA; Continuous Precision
Medicine, Research Triangle Park, NC;
CSP Technologies, Inc., Auburn, AL;
CTD Group LLC, Vashon, WA; Daxor
Corp., Oak Ridge, TN; Decisive Point
Group, Beacon, NY; DermiSense, Inc.,
Richmond, VA; DHR Health Institute for
Research and Development, Edinburg,
TX; Dog Tag Buddies, Billings, MT; DPrime LLC, McLean, VA; Drexel
University, Philadelphia, PA; Eagle
Global Scientific LLC, San Antonio, TX;
Endoluxe, Inc., Dunwoody, GA;
Endomedix, Inc., Montclair, NJ;
Engineering & Computer Simulations,
Inc., Orlando, FL; Entasis Therapeutics,
Waltham, MA; FireFlare Games LLC,
Cheyenne, WY; Float Lab Technologies,
Inc., Venice, CA; Foothold Labs, Inc.,
Olathe, KS; Gel4Med, Lowell, MA;
GelMEDIX, Inc., Newton, MA; GelSana
Therapeutics, Inc., Aurora, CO; Global
Resonance Technologies LLC,
Shelburne, VT; Grand Valley State
University, Grand Rapids, MI; Hafion,
Inc., Ann Arbor, MI; Hope 4 You Global
LLC, Lowell, AR; Hubly, Inc. dba Hubly
Surgical, Evanston, IL; Human Systems
Integration, Inc., East Walpole, MA;
Icahn School of Medicine at Mount
Sinai, New York, NY; ICON Government
and Public Health Solutions, Hinckley,
OH; Idion, Inc., Darien, CT; iFyber LLC,
Ithaca, NY; Incell Corp. LLC, San
Antonio, TX; IOTAI, Inc., Fremont, CA;
Jana Care, Inc., Watertown, MA; JC3
LLC, Rockbridge Baths, VA; Joint
Research and Development, Inc.,
Stafford, VA; Jurata Thin Film, Inc.,
Chapel Hill, NC; K9s for Warriors, Ponte
Vedra Beach, FL; KBR, Beavercreek, OH;
Kerecis, Ltd., Isafjordur, ICELAND;
Longhorn Vaccines and Diagnostics
LLC, Bethesda, MD; Lynntech, Inc.,
College Station, TX; Manzanita
Pharmaceuticals, Inc., Woodside, CA;
Maravai Life Sciences, San Diego, CA;
MCPC, Cleveland, OH; Mechano
Therapeutics LLC, Philadelphia, PA;
MediView XR, Inc., Cleveland, OH;
Medtronic, Minneapolis, MN; MeMed
US, Inc., Milpitas, CA; Methodist
Hospital Research Institute dba Houston
Methodist Research Institute, Houston,
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
52091
TX; Microbion Corp., Bozeman, MT;
Milestone Scientific, Inc., Roseland, NJ;
MiMedx Group, Inc., Marietta, GA;
Muscle Activation Techniques,
Englewood, CO; MVK Pharmaceuticals
LLC, Indianapolis, IN; My Buddies
Place, Inc., Pasadena, CA; Nakamir, Inc.,
Palo Alto, CA; Neurotrauma Sciences
LLC, Alpharetta, GA; New York
University School of Medicine, New
York, NY; nFlux, Inc., Palm Springs,
CA; NightHawk Biosciences, Inc.,
Morrisville, NC; Nihon Kohden
OrangeMed, Inc., Santa Ana, CA; North
Carolina Biotechnology Center,
Research Triangle Park, NC;
NovoPedics, Inc., Princeton, NJ; Nyrada,
Inc., Gordon, AUSTRALIA; Odic, Inc.,
Littleton, MA; Omnicure, Inc., Ladue,
MO; Oregon Biomedical Engineering
Institute, Inc., Wilsonville, OR;
OrganaBio LLC, South Miami, FL;
Orthoforge, Inc., East Grand Rapids, MI;
Otter Cove Solutions LLC, Gaithersburg,
MD; Pacific Institute for Research and
Evaluation, Beltsville, MD; Padagis US
LLC, Allegan, MI; Palantir USG, Inc.,
Palo Alto, CA; PathoGene, Inc.,
Monrovia, CA; Paxauris LLC, Phoenix,
AZ; Phagelux, Inc., Montréal, CANADA;
Philips North America LLC, Cambridge,
MA; Population Sleep LLC, Dallas, TX;
PortaVision Medical LLC, Jefferson, LA;
ppx-TEC LLC, Jackson, MS; Precision
Trauma LLC, Columbus, GA; Problem
Solutions LLC, Johnstown, PA;
Prohuman Technologies, Concord, NC;
Promethean LifeSciences, Inc.,
Pittsburgh, PA; Purdue University, West
Lafayette, IN; Red One Medical Devices
LLC, Savannah, GA; Regenerative
Processing Plant LLC, Tampa, FL;
Regranion LLC, Mt. Pleasant, SC;
Renerva LLC, Pittsburgh, PA; Resilient
Lifescience, Inc., Pittsburgh, PA;
Reveille Group, Tampa, FL; Rock West
Composites, Inc., San Diego, CA; RSTSanexas, Las Vegas, NV; SafeBeat Rx,
Inc., Chico, CA; SafeBVM Corp., Boston,
MA; Safeguard Surgical, Tampa, FL;
Safi Biotherapeutics, Inc., Cambridge,
MA; Saint Barnabas Medical Center,
Livingston, NJ; Saint Louis University,
St. Louis, MO; Sanofi Pasteur,
Swiftwater, PA; Scientific & Biomedical
Microsystems LLC, Glen Burnie, MD;
SeaStar Medical, Inc., Denver, CO;
Securisyn Medical LLC, Highlands
Ranch, CO; Senseye, Inc., Austin, TX;
Shee Atiká Enterprises, Huntsville, AL;
Sherpa 6, Inc., Littleton, CO; Shipcom
Federal Solutions LLC, Belcamp, MD;
SLSCO, Ltd., Galveston, TX; Softox
Solutions AS, Fornebu, Norway;
Soliyarn, Belmont, MA; Sophic
Synergistics LLC, Houston, TX; Sparta
Biomedical, Inc., Chatham, NJ; SPEAR
Human Performance, Inc., Sandy
E:\FR\FM\21JNN1.SGM
21JNN1
52092
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
Springs, GA; SpineThera, Inc.,
Plymouth, MN; Steadman Philippon
Research Institute, Vail, CO; Stellarray,
Inc., Austin, TX; Sterogene
Bioseparations, Inc., Carlsbad, CA;
TechEn, Inc., Milford, MA; Terasaki
Institute for Biomedical Innovation, Los
Angeles, CA; Texas A&M University,
College Station, TX; Texas Research &
Technology Foundation, San Antonio,
TX; The Emmes Company LLC,
Rockville, MD; The Research Institute of
the McGill University Health Centre,
Montreal, CANADA; TiER1 Performance
Solutions, Covington, KY; Transom
Scopes, Inc. dba Instrument
Technology, Inc., Westfield, MA;
Trustees of the University of
Pennsylvania, Philadelphia, PA; UCHU
Biosensors, Inc., Newark, NJ; University
of Miami, Coral Gables, FL; University
of Southern California, Los Angeles, CA;
U-Smell-It LLC, Guilford, CT; Vaxxas,
Cambridge, MA; Viele Exploratory
Sustainable Solutions LLC, Livingston
Manor, NY; Virion Therapeutics LLC,
Newark, DE; Weinberg Medical Physics,
Inc., North Bethesda, MD; Westat, Inc.,
Rockville, MD; Xheme, Inc., Newton,
MA; Xomix, Ltd., Chicago, IL; and ZeSa
LLC, Eden Prarie, MN have withdrawn
as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on January 9, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on February 6, 2024 (89 FR 8246).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13611 Filed 6–20–24; 8:45 am]
BILLING CODE P
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF JUSTICE
Antitrust Division
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), ODVA, Inc.
(‘‘ODVA’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, NIRECO CORPORATION,
Tokyo, JAPAN; BEIJING JIYUAN
AUTOMATION TECHNOLOGY CO.,
LTD, Beijing, PEOPLE’S REPUBLIC OF
CHINA; WERMA Signaltechnik GmbH +
CO. KG, Rietheim-Weilheim,
GERMANY; ISH Ingenieursozietät
GmbH, Kreuztal, North RhineWestphalia, GERMANY; WITTENSTEIN
cyber motor GmbH, Igersheim, BadenWürttemberg, GERMANY; Elementary
Robotics Inc, South Pasadena, CA;
Synapticon GmbH, Schönaich, BadenWürtemberg, GERMANY; Eura Drives
Electric Co., Ltd, Yantai, Shandong,
PEOPLE’S REPUBLIC OF CHINA;
MYUNGBO CABLE, Hwaseong-si,
Gyeonggi-do, REPUBLIC OF KOREA;
TMSS France, Rueil-Malmaison, Haute
de Seine, FRANCE, have been added as
parties to this venture.
Also, CMD Corporation, Appleton,
WI; Hangzhou Hikrobot Technology Co.,
Ltd., HangZhou, ZheJiang, PEOPLE’S
REPUBLIC OF CHINA; Sanwa
Engineering Corp., Hsinchu County,
TAIWAN, have withdrawn as parties to
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ODVA
intends to file additional written
notifications disclosing all changes in
membership.
On June 21, 1995, ODVA filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on February 15, 1996 (61 FR 6039).
The last notification was filed with
the Department on December 8, 2023. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on February 5, 2024 (89 FR 7730).
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—ODVA, Inc.
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
Notice is hereby given that, on April
4, 2024, pursuant to section 6(a) of the
National Cooperative Research and
[FR Doc. 2024–13619 Filed 6–20–24; 8:45 am]
VerDate Sep<11>2014
17:46 Jun 20, 2024
Jkt 262001
BILLING CODE P
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—ASTM International
Notice is hereby given that, on May
17, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), ASTM International
(‘‘ASTM’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, ASTM has provided an
updated list of current, ongoing ASTM
activities originating between February
10, 2024, and May 12, 2024, designated
as Work Items. A complete listing of
ASTM Work Items, along with a brief
description of each, is available at
https://www.astm.org.
On September 15, 2004, ASTM filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on November 10, 2004
(69 FR 65226).
The last notification was filed with
the Department on February 28, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on March 13, 2024 (89 FR 18437).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13657 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—America’s DataHub
Consortium
Notice is hereby given that, on April
4, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), America’s DataHub
Consortium (‘‘ADC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
E:\FR\FM\21JNN1.SGM
21JNN1
Agencies
[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52090-52092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13611]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on April 2, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC''), has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, 10x National Security, Aldie, VA; 4WEB, Inc., Frisco, TX;
Abram Scientific, Inc., South San Francisco, CA; Admetsys Corp.,
Boston, MA; Advanced RNA Vaccine Technologies, Inc., North Bethesda,
MD; Aergility Corp., Dunnellon, FL; Airway Shield S.L., Santander
Cantabria, Spain; AmacaThera, Inc., Toronto, CANADA; Ampel LLC,
Charlottesville, VA; Anthos Group, Inc., Torrance, CA; Apos US
Management, Inc., New York, NY; Asynchealth, Pebble Beach, CA; Baebies,
Inc., Durham, NC; Best Practice Associates LLC dba Tria Federal,
Arlington, VA; Bio-Change, Ltd., Yokneam, ISRAEL; Black Fur Biomedical,
Tucson, AZ; Blue Spark Technologies, Inc., Westlake, OH; Board of
Regents, Nevada System of Higher Education on behalf of the University
of Nevada, Las Vegas, Las Vegas, NV; Board of the Trustees of the
Colorado School of Mines, Golden, CO; Cadet NM, Inc., Albuquerque, NM;
Cambridge Research & Development, Inc., Nashua, NH; Canaery, Alachua,
FL; Coldplasmatech GmbH, Greifswald, GERMANY; ComeBack Mobility, Inc.,
New York, NY; CoolSpine LLC, Woodbury, CT; Cristae Consulting LLC,
Moorestown, NJ; Directed Systems, Ltd., Cambridge, UNITED KINGDOM;
Eluciderm, Inc., San Diego, CA; ExThera Medical Corp., Martinez, CA;
EyeYon Medical, Ltd., Ness Ziona, ISRAEL; Florida Institute of
Technology, Melbourne, FL; FluidForm, Inc., Waltham, MA; Gigantor
Technologies, Inc., Melbourne Beach, FL; Global Virtual Training LLC,
New York, NY; GoodCap Pharmaceuticals, Toronto, CANADA; Hatch Product
Development LLC, Waukegan, IL; Henley Ion LLC, New Orleans, LA; Idea
Meds, Inc., New York, NY; Immense Dynamics, Inc., Bremerton, WA;
Innovative Health Sciences LLC, Chester, NY; Innovosens AB, Inc.,
Wilmington, DE; Interoperability Institute LLC, Lansing, MI; JustBard
Technologies LLC, Brunswick, MD; KaloCyte, Inc., Baltimore, MD; LaCire
LLC, Alexandria, VA; Lankenau Institute for Medical Research,
Wynnewood, PA; Loma Linda University, Loma Linda, CA; Lucid Reality
Labs LLC, Miami, FL; LumaFlo, Inc., Detroit, MI; Lundquist Institute
for Medical Innovation at Harbor-UCLA Medical Center, Torrance, CA;
Medasense Biometrics, Ltd., Ramat Gan, ISRAEL; MediCarbone, Inc.,
Tuscon, AZ; Mitochon Pharmaceuticals, Inc., Blue Bell, PA; Modular
Matter, Inc., Abingdon, MD; Moonrise Medical, Inc., Oakville, CANADA;
Noleus Technologies, Inc., Houston, TX; Nou Systems, Inc., Huntsville,
AL; Noxy Health Products, Inc., Anaconda, MT; Oak Grove Technologies,
Raleigh, NC; Obsidian Solutions Group, Fredericksburg, VA; Omniox,
Inc., San Francisco, CA; Osetomics LLC, Glen Mills, PA; Osteolyse,
Inc., Soda Springs, CA; Owl Therapeutics, San Antonio,
[[Page 52091]]
TX; PathKeeper Surgical, Ltd., Kfar Saba, ISRAEL; PyrAmes, Inc.,
Cupertino, CA; Qidni Labs, Inc., Buffalo, NY; Rafa Laboratories, Ltd.,
Jerusalem, ISRAEL; ReBlood Rx LLC, San Diego, CA; Regerna Therapeutics,
Inc., New York, NY; Regulatory Quality Management Information Source,
Inc., Amesbury, MA; Remedor Biomed Ltd., Nof Hagalil, ISRAEL; Renovera,
PBC, West Lafayette, IN; Respair, Inc., Pittsburgh, PA; RevBio, Inc.,
Lowell, MA; Rion, Inc., Rochester, MN; Saforax Health, Haifa, ISRAEL;
SCHOTT North America New Ventures, Duryea, PA; SenseVOC LLC, Littleton,
CO; Serda B.V., Amsterdam, THE NETHERLANDS; SMSbiotech, Inc., San
Marcos, CA; Stanford University, Stanford, CA; STEER Tech LLC,
Annapolis Junction, MD; Synapstim Ltd., Herzliya, ISRAEL; Temple
University--Of The Commonwealth System of Higher Education,
Philadelphia, PA; The Hospital for Special Surgery Fund, Inc., New
York, NY; The Institute for Integrative and Innovative Research at the
University of Arkansas, Fayetteville, Fayetteville, AK; Tietronix
Software, Inc., Houston, TX; TYBR Health, Inc., Houston, TX; Unit
Medical Devices, Ltd., Sderot, ISRAEL; University of Arkansas, Little
Rock, Little Rock, AR; University of Cincinnati, Cincinnati, OH;
Valiant Harbor International LLC, Bethesda, MD; Vasomune Therapeutics
US, Inc., Raleigh, NC; Velico Medical, Inc., Beverly, MA; ViBo Health,
Inc., Los Angeles, CA; Videra Health, Inc., Orem, UT; Vir
Biotechnology, San Francisco, CA; ViyaMD, Inc., Marina del Rey, CA;
Western Michigan University Homer Stryker M.D. School of Medicine,
Kalamazoo, MI; and XO Armor Technologies, Inc., Auburn, AL have been
added as parties to this venture.
Also, 2C4 Technologies, Inc., San Antonio, TX; AbViro LLC,
Bethesda, MD; Acer Therapeutics, Inc., Newton, MA; Advanced Surgical
Retractor Systems, Inc., Shavano Park, TX; Allied Technologies and
Consulting LLC, Frederick, MD; Amend Surgical, Inc., Alachua, FL;
American Military Families Action Network, Tacoma, WA; American Type
Culture Collection, Manassas, VA; AMK Technologies of Ohio LLC, Mount
Vernon, OH; Anchor Therapy Clinic, Sacramento, CA; Applied Research
Center, Aiken, SC; Arcascope, Inc., Arlington, VA; Aruna Bio, Inc.,
Athens, GA; Asante Bio, Tampa, FL; Atorvia Health Technologies, Inc.,
Ottawa, Ontario, CANADA; Avel eCare LLC, Sioux Falls, SD; Axioforce,
Inc., St. Louis, MO; Bio1 Systems, Inc., San Carlos, CA; BioAge Labs,
Inc., Richmond, CA; Biobeat Technologies, Ltd., Petach Tikva, ISRAEL;
Bionet Sonar, Inc., Burlington, MA; BiotechPharma Corp., Severna Park,
MD; Board of Trustees of the University of Illinois, Champaign, IL;
Bodies Done Right, Mayfield Village, OH; California Service Dog
Academy, Visalia, CA; Capital Factory Properties LLC, Austin, TX;
Channel Clinical Solutions LLC, Raleigh, NC; Children's Hospital Los
Angeles, Los Angeles, CA; ClearCoast USA LLC, St. Petersburg, FL;
Concurrent Technologies Corp., Johnstown, PA; Conseqta Technology,
Arlington, VA; Continuous Precision Medicine, Research Triangle Park,
NC; CSP Technologies, Inc., Auburn, AL; CTD Group LLC, Vashon, WA;
Daxor Corp., Oak Ridge, TN; Decisive Point Group, Beacon, NY;
DermiSense, Inc., Richmond, VA; DHR Health Institute for Research and
Development, Edinburg, TX; Dog Tag Buddies, Billings, MT; D-Prime LLC,
McLean, VA; Drexel University, Philadelphia, PA; Eagle Global
Scientific LLC, San Antonio, TX; Endoluxe, Inc., Dunwoody, GA;
Endomedix, Inc., Montclair, NJ; Engineering & Computer Simulations,
Inc., Orlando, FL; Entasis Therapeutics, Waltham, MA; FireFlare Games
LLC, Cheyenne, WY; Float Lab Technologies, Inc., Venice, CA; Foothold
Labs, Inc., Olathe, KS; Gel4Med, Lowell, MA; GelMEDIX, Inc., Newton,
MA; GelSana Therapeutics, Inc., Aurora, CO; Global Resonance
Technologies LLC, Shelburne, VT; Grand Valley State University, Grand
Rapids, MI; Hafion, Inc., Ann Arbor, MI; Hope 4 You Global LLC, Lowell,
AR; Hubly, Inc. dba Hubly Surgical, Evanston, IL; Human Systems
Integration, Inc., East Walpole, MA; Icahn School of Medicine at Mount
Sinai, New York, NY; ICON Government and Public Health Solutions,
Hinckley, OH; Idion, Inc., Darien, CT; iFyber LLC, Ithaca, NY; Incell
Corp. LLC, San Antonio, TX; IOTAI, Inc., Fremont, CA; Jana Care, Inc.,
Watertown, MA; JC3 LLC, Rockbridge Baths, VA; Joint Research and
Development, Inc., Stafford, VA; Jurata Thin Film, Inc., Chapel Hill,
NC; K9s for Warriors, Ponte Vedra Beach, FL; KBR, Beavercreek, OH;
Kerecis, Ltd., Isafjordur, ICELAND; Longhorn Vaccines and Diagnostics
LLC, Bethesda, MD; Lynntech, Inc., College Station, TX; Manzanita
Pharmaceuticals, Inc., Woodside, CA; Maravai Life Sciences, San Diego,
CA; MCPC, Cleveland, OH; Mechano Therapeutics LLC, Philadelphia, PA;
MediView XR, Inc., Cleveland, OH; Medtronic, Minneapolis, MN; MeMed US,
Inc., Milpitas, CA; Methodist Hospital Research Institute dba Houston
Methodist Research Institute, Houston, TX; Microbion Corp., Bozeman,
MT; Milestone Scientific, Inc., Roseland, NJ; MiMedx Group, Inc.,
Marietta, GA; Muscle Activation Techniques, Englewood, CO; MVK
Pharmaceuticals LLC, Indianapolis, IN; My Buddies Place, Inc.,
Pasadena, CA; Nakamir, Inc., Palo Alto, CA; Neurotrauma Sciences LLC,
Alpharetta, GA; New York University School of Medicine, New York, NY;
nFlux, Inc., Palm Springs, CA; NightHawk Biosciences, Inc.,
Morrisville, NC; Nihon Kohden OrangeMed, Inc., Santa Ana, CA; North
Carolina Biotechnology Center, Research Triangle Park, NC; NovoPedics,
Inc., Princeton, NJ; Nyrada, Inc., Gordon, AUSTRALIA; Odic, Inc.,
Littleton, MA; Omnicure, Inc., Ladue, MO; Oregon Biomedical Engineering
Institute, Inc., Wilsonville, OR; OrganaBio LLC, South Miami, FL;
Orthoforge, Inc., East Grand Rapids, MI; Otter Cove Solutions LLC,
Gaithersburg, MD; Pacific Institute for Research and Evaluation,
Beltsville, MD; Padagis US LLC, Allegan, MI; Palantir USG, Inc., Palo
Alto, CA; PathoGene, Inc., Monrovia, CA; Paxauris LLC, Phoenix, AZ;
Phagelux, Inc., Montr[eacute]al, CANADA; Philips North America LLC,
Cambridge, MA; Population Sleep LLC, Dallas, TX; PortaVision Medical
LLC, Jefferson, LA; ppx-TEC LLC, Jackson, MS; Precision Trauma LLC,
Columbus, GA; Problem Solutions LLC, Johnstown, PA; Prohuman
Technologies, Concord, NC; Promethean LifeSciences, Inc., Pittsburgh,
PA; Purdue University, West Lafayette, IN; Red One Medical Devices LLC,
Savannah, GA; Regenerative Processing Plant LLC, Tampa, FL; Regranion
LLC, Mt. Pleasant, SC; Renerva LLC, Pittsburgh, PA; Resilient
Lifescience, Inc., Pittsburgh, PA; Reveille Group, Tampa, FL; Rock West
Composites, Inc., San Diego, CA; RST-Sanexas, Las Vegas, NV; SafeBeat
Rx, Inc., Chico, CA; SafeBVM Corp., Boston, MA; Safeguard Surgical,
Tampa, FL; Safi Biotherapeutics, Inc., Cambridge, MA; Saint Barnabas
Medical Center, Livingston, NJ; Saint Louis University, St. Louis, MO;
Sanofi Pasteur, Swiftwater, PA; Scientific & Biomedical Microsystems
LLC, Glen Burnie, MD; SeaStar Medical, Inc., Denver, CO; Securisyn
Medical LLC, Highlands Ranch, CO; Senseye, Inc., Austin, TX; Shee
Atik[aacute] Enterprises, Huntsville, AL; Sherpa 6, Inc., Littleton,
CO; Shipcom Federal Solutions LLC, Belcamp, MD; SLSCO, Ltd., Galveston,
TX; Softox Solutions AS, Fornebu, Norway; Soliyarn, Belmont, MA; Sophic
Synergistics LLC, Houston, TX; Sparta Biomedical, Inc., Chatham, NJ;
SPEAR Human Performance, Inc., Sandy
[[Page 52092]]
Springs, GA; SpineThera, Inc., Plymouth, MN; Steadman Philippon
Research Institute, Vail, CO; Stellarray, Inc., Austin, TX; Sterogene
Bioseparations, Inc., Carlsbad, CA; TechEn, Inc., Milford, MA; Terasaki
Institute for Biomedical Innovation, Los Angeles, CA; Texas A&M
University, College Station, TX; Texas Research & Technology
Foundation, San Antonio, TX; The Emmes Company LLC, Rockville, MD; The
Research Institute of the McGill University Health Centre, Montreal,
CANADA; TiER1 Performance Solutions, Covington, KY; Transom Scopes,
Inc. dba Instrument Technology, Inc., Westfield, MA; Trustees of the
University of Pennsylvania, Philadelphia, PA; UCHU Biosensors, Inc.,
Newark, NJ; University of Miami, Coral Gables, FL; University of
Southern California, Los Angeles, CA; U-Smell-It LLC, Guilford, CT;
Vaxxas, Cambridge, MA; Viele Exploratory Sustainable Solutions LLC,
Livingston Manor, NY; Virion Therapeutics LLC, Newark, DE; Weinberg
Medical Physics, Inc., North Bethesda, MD; Westat, Inc., Rockville, MD;
Xheme, Inc., Newton, MA; Xomix, Ltd., Chicago, IL; and ZeSa LLC, Eden
Prarie, MN have withdrawn as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on January 9,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on February 6, 2024 (89 FR 8246).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13611 Filed 6-20-24; 8:45 am]
BILLING CODE P